Michael is Vice President, Business Development, at PAREXEL International, Inc. where his team’s mission is to help drug discovery, device, and diagnostic companies accelerate the development of new therapies for human disease. Michael has been a board member of the Cutaneous Lymphoma Foundation since 2002 and currently serves on its Board Governance and Development Committees.
In 2001, he was named Medical Marketer of the Year by the Medical Marketing Association and in 2003 served as President of the national organization. In 2004 he was awarded the Leadership Award by Ligand Pharmaceuticals for the second time in three years and, in 2005, was recognized by the International Society for Cutaneous Lymphomas (ISCL) for his industry-leading work with the organization. He also serves on several formal committees within the US Cutaneous Lymphoma Consortium (USCLC). He has been intimately involved in the development of several currently available therapies for the management of CTCL since 1995.
Among his other credentials, Michael has been an active industry speaker and author. He has presented at numerous conferences including The Association of Strategic Alliance Professionals (ASAP), the Biotechnology Industry Organization (BIO), the American Association of Pharmaceutical Sciences, the Sino-America Biotechnology and Pharmaceutical Association (SABPA), and the Drug Information Association (DIA).
Michael and his family live in San Diego, CA.
This is an automatic translation service and therefore the
Cutaneous Lymphoma Foundation is not responsible
for any potential translation inaccuracies.